AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 89 filers reported holding AUDENTES THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,581,000 | +252600.0% | 126,695 | +118306.5% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 107 | +13.8% | 0.00% | – |
| Q2 2019 | $4,000 | +100.0% | 94 | +84.3% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 51 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -97.1% | 51 | -94.1% | 0.00% | – |
| Q3 2018 | $34,000 | +466.7% | 865 | +424.2% | 0.00% | – |
| Q2 2018 | $6,000 | +200.0% | 165 | +211.3% | 0.00% | – |
| Q1 2018 | $2,000 | -33.3% | 53 | -23.2% | 0.00% | – |
| Q4 2017 | $3,000 | -92.5% | 69 | -95.1% | 0.00% | – |
| Q3 2017 | $40,000 | +3900.0% | 1,419 | +2527.8% | 0.00% | – |
| Q2 2017 | $1,000 | -80.0% | 54 | -79.9% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 268 | -0.7% | 0.00% | – |
| Q4 2016 | $5,000 | +150.0% | 270 | +170.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $36,198,681,000 | 11.58% |
| Sofinnova Investments, Inc. | 1,380,303 | $41,478,000 | 7.13% |
| Casdin Capital, LLC | 450,000 | $13,523,000 | 2.38% |
| Foresite Capital Management III, LLC | 315,331 | $9,476,000 | 2.06% |
| Opaleye Management Inc. | 190,000 | $5,709,000 | 1.63% |
| Redmile Group, LLC | 1,308,526 | $39,321,000 | 1.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,384,470 | $41,603,000 | 1.44% |
| Orbimed Advisors | 3,522,100 | $105,839,000 | 1.31% |
| Rock Springs Capital Management LP | 565,000 | $16,978,000 | 0.72% |
| Cormorant Asset Management, LP | 322,945 | $9,704,000 | 0.72% |